REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 91 filers reported holding REVOLUTION MEDICINES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,440,158 | -8.0% | 88,156 | -11.1% | 0.00% | 0.0% |
| Q2 2023 | $2,651,835 | +21.3% | 99,134 | -1.8% | 0.00% | +33.3% |
| Q1 2023 | $2,186,859 | +10.0% | 100,963 | +21.0% | 0.00% | 0.0% |
| Q4 2022 | $1,988,255 | +24.4% | 83,470 | +3.0% | 0.00% | 0.0% |
| Q3 2022 | $1,598,000 | +27.0% | 81,052 | +25.5% | 0.00% | +50.0% |
| Q2 2022 | $1,258,000 | -25.7% | 64,561 | -2.8% | 0.00% | 0.0% |
| Q1 2022 | $1,694,000 | -7.8% | 66,421 | -9.0% | 0.00% | 0.0% |
| Q4 2021 | $1,837,000 | -6.1% | 72,996 | +2.6% | 0.00% | -33.3% |
| Q3 2021 | $1,956,000 | -24.7% | 71,114 | -13.1% | 0.00% | 0.0% |
| Q2 2021 | $2,598,000 | -12.1% | 81,855 | +27.1% | 0.00% | -25.0% |
| Q1 2021 | $2,956,000 | +27.1% | 64,427 | +9.7% | 0.00% | +33.3% |
| Q4 2020 | $2,325,000 | +14.4% | 58,739 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $2,032,000 | +199.7% | 58,384 | +172.0% | 0.00% | +200.0% |
| Q2 2020 | $678,000 | +44.3% | 21,466 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $470,000 | – | 21,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |